Unexpected Results of an Obvious Process are Non-obvious


In Millennium Pharmaceuticals, Inc., v. Sandoz Inc. , [2015-2066, 2016-1008, 2016-1009, 2016-1010, 2016-1109, 2016-1110, 2016-1283, 2016-1762] , the Federal Circuit reversed the district court, finding that invalidity was not established.



from Biotech News